We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

190 hedge funds and large institutions have $3.37B invested in Medicines Co in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 70 increasing their positions, 73 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less capital invested

Capital invested by funds: $3.5B → $3.37B (-$128M)

4% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 73

6% less funds holding

Funds holding: 202 → 190 (-12)

17% less funds holding in top 10

Funds holding in top 10: 12 → 10 (-2)

20% less call options, than puts

Call options by funds: $40.8M | Put options by funds: $50.9M

33% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 30

Holders
190
Holders Change
-12
Holders Change %
-5.94%
% of All Funds
4.74%
Holding in Top 10
10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-16.67%
% of All Funds
0.25%
New
20
Increased
70
Reduced
73
Closed
30
Calls
$40.8M
Puts
$50.9M
Net Calls
-$10.1M
Net Calls Change
-$50.2M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$33.7M
2
ACA
Avoro Capital Advisors
New York
+$22.5M
3
PC
PointState Capital
New York
+$21.3M
4
SPC
Slate Path Capital
New York
+$20.8M
5
PI
Putnam Investments
Massachusetts
+$19.5M

Top Sellers

Rank Fund Capital Flow
1
IAM
Iridian Asset Management
Connecticut
-$70.6M
2
FCM
Frontier Capital Management
Massachusetts
-$27M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$21.1M
4
CM
Corvex Management
New York
-$19.7M
5
AA
Antipodean Advisors
New York
-$14.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
76
Credit Suisse
Switzerland
$3.45M +$1.46M +39,565 +74%
Canada Life
77
Canada Life
Manitoba, Canada
$3.24M -$628K -17,023 -16%
LPC
78
Lion Point Capital
New York
$3.22M – – –
ACM
79
Atika Capital Management
New York
$2.89M -$4.13M -112,000 -59%
Millennium Management
80
Millennium Management
New York
$2.79M +$826K +22,416 +42%
SEI Investments
81
SEI Investments
Pennsylvania
$2.54M -$2.32M -62,932 -48%
NFA
82
Nationwide Fund Advisors
Ohio
$2.53M +$5.64K +153 +0.2%
American Century Companies
83
American Century Companies
Missouri
$2.3M +$17K +460 +0.7%
Citadel Advisors
84
Citadel Advisors
Florida
$2.24M -$3.99M -108,124 -64%
MOACM
85
Mutual of America Capital Management
New York
$2.17M – – –
State of Tennessee, Department of Treasury
86
State of Tennessee, Department of Treasury
Tennessee
$2.07M -$401K -10,886 -16%
PI
87
PineBridge Investments
New York
$2.07M -$1.14K -31 -0.1%
UBS Group
88
UBS Group
Switzerland
$2.05M +$1.95K +53 +0.1%
AIG
89
American International Group
New York
$2M +$71.8K +1,947 +4%
Manulife (Manufacturers Life Insurance)
90
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.95M -$25.6K -694 -1%
Comerica Bank
91
Comerica Bank
Texas
$1.93M -$298K -8,089 -11%
State of Wisconsin Investment Board
92
State of Wisconsin Investment Board
Wisconsin
$1.93M – – –
TF
93
TIAA FSB
Florida
$1.87M – – –
ProShare Advisors
94
ProShare Advisors
Maryland
$1.79M +$99.3K +2,695 +6%
TPSF
95
Texas Permanent School Fund
Texas
$1.73M -$222K -6,024 -11%
MLICM
96
Metropolitan Life Insurance Company (MetLife)
New York
$1.71M – – –
Public Sector Pension Investment Board (PSP Investments)
97
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.49M +$129K +3,491 +9%
State Board of Administration of Florida Retirement System
98
State Board of Administration of Florida Retirement System
Florida
$1.47M – – –
Thrivent Financial for Lutherans
99
Thrivent Financial for Lutherans
Minnesota
$1.43M -$180K -4,890 -11%
Parallax Volatility Advisers
100
Parallax Volatility Advisers
California
$1.41M +$1.4M +38,043 New
2 3
4
5 6

MDCO Hedge Fund Activity: Q3 2017 in Review

190 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q3 2017, worth a combined $3.37B — down 3.7% from $3.5B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of MDCO and 20 opened new positions — a net loss of 10 holders — while 73 trimmed existing stakes and 70 added.

The largest buyer was Goldman Sachs, adding an estimated $33.7M. The largest seller was Iridian Asset Management, cutting an estimated $70.6M.

  • 190 institutional investors held Medicines Co (MDCO) as of Q3 2017, down from 202 in Q2 2017.
  • Funds reported $3.37B of Medicines Co stock for Q3 2017, down 3.7% quarter-over-quarter.
  • 20 funds opened new Medicines Co positions in Q3 2017 and 30 closed out, a net change of -10 holders.
  • The largest Medicines Co buyer in Q3 2017 was Goldman Sachs, an estimated $33.7M added.
  • The largest Medicines Co seller in Q3 2017 was Iridian Asset Management, an estimated $70.6M sold.

Based on aggregated 13F filings for Q3 2017.